Entero Healthcare (ENTERO) | Stock Overview & Key Data
Entero Healthcare Performance Comparison
Stock Range
Today's Range
Low: ₹1,196.10
High: ₹1,225.90
on August 14, 2025
52 Week Range
Low: ₹1,080.00
High: ₹1,584.25
on April 7, 2025
on November 7, 2024
All-Time High: ₹1,584.25 on November 4, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR52.5B
EPS
23.52
P/E Ratio (TTM)
51.29
Forward P/E
23.58
P/B Ratio
3.04
PEG Ratio
1.34
Div. Yield
N/A
ROE
5.36%
Beta
N/A
Debt to Equity
21.76
Financial Highlights
Profitability
Gross Margin
9.94%
Operating Margin
2.94%
Profit Margin
1.90%
Returns and Earnings
Return on Assets (TTM)
3.51%
Return on Equity (TTM)
5.36%
EBITDA
INR2.2B
Net Income (TTM)
INR1.0B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR1,241.75
Quarterly Revenue Growth (YoY)
28.00%
Quarterly Earnings Growth (YoY)
38.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Entero Healthcare ENTERO | 52.49B Mid-cap | -4.11% | -3.93% | -17.10% | -1.97% | -15.97% | -2.62% | 4.95% | 4.95% |
| Amwill Health Care AMWILL | 1.25B Small-cap | 3.51% | -6.30% | -31.56% | -36.48% | -32.98% | -36.48% | -36.48% | -36.48% |
| Royal Sense ROYAL | 1.22B Small-cap | 14.15% | 9.12% | 7.88% | -9.88% | -23.53% | 57.26% | 109.92% | 109.92% |
| NOVELIX NOVELIX | 534.47M Small-cap | -5.90% | -21.44% | 42.13% | 49.23% | 49.23% | 49.23% | 49.23% | 49.23% |
| Trimurthi TRIMURTHI | 264.77M Small-cap | -5.90% | -21.44% | 42.13% | 56.65% | 64.43% | 90.27% | 422.50% | 1,061.11% |
| Zenlabs Ethica ZENLABS | 199.99M Small-cap | -6.82% | -13.83% | -3.70% | -8.71% | -23.24% | -21.03% | -32.56% | 20.71% |
Ownership & Short Interest
Insider Ownership
62.92%
Institutional Ownership
21.53%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
63K
Average 90-Day Volume
77K
Entero Healthcare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Entero Healthcare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ENTERO's 52-week high and low?
- In the last 52 weeks, Entero Healthcare reached a high of ₹1,584.25 (on November 7, 2024) and a low of ₹1,080.00 (on April 7, 2025).
- What is the market cap and P/E ratio for ENTERO?
- Curious about Entero Healthcare's size and valuation? Its market capitalization stands at 52.49B. When it comes to valuation, the P/E ratio (trailing twelve months) is 51.29, and the forward P/E (looking ahead) is 23.58.
- Does ENTERO pay dividends? If so, what's the yield?
- As for dividends, Entero Healthcare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Entero Healthcare's main competitors or similar companies to consider before investing?
When looking at Entero Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Amwill Health Care
AMWILL1.25B Healthcare Medical Distribution -36.48% -36.48% Royal Sense
ROYAL1.22B Healthcare Medical Distribution 57.26% 109.92% NOVELIX
NOVELIX534.47M Healthcare Medical Distribution 49.23% 49.23% Trimurthi
TRIMURTHI264.77M Healthcare Medical Distribution 90.27% 422.50% Zenlabs Ethica
ZENLABS199.99M Healthcare Medical Distribution -21.03% -32.56% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Entero Healthcare Solutions? (e.g., ROE, Debt/Equity)
- To get a sense of Entero Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.36%, the Debt to Equity ratio from the most recent quarter is 21.76, and its Gross Profit Margin stands at 9.94%.
- What is the recent revenue and earnings growth for ENTERO?
- Looking at Entero Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR54B. Compared to the same quarter last year (YoY), quarterly revenue grew by 28.00%, and quarterly earnings saw a YoY growth of 38.40%.
- How much of ENTERO stock is held by insiders and institutions?
- Wondering who owns Entero Healthcare stock? Company insiders (like executives and directors) hold about 62.92% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 21.53%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.